Automated Hovering for Congestive Heart Failure Patients

NACompletedINTERVENTIONAL
Enrollment

566

Participants

Timeline

Start Date

May 22, 2016

Primary Completion Date

April 7, 2020

Study Completion Date

December 31, 2021

Conditions
Heart Failure
Interventions
BEHAVIORAL

Electronic pill bottle

Participant adherence to their diuretic will be monitored on a daily basis and participants will be contacted if they are non-adherence to this medication

BEHAVIORAL

Bluetooth scale

Participant adherence to stepping on their scale will be monitored on a daily basis and participants will be contacted if they are non-adherent to weighing-in. Participant weight gain will also be monitored, and if weight gain exceeds a specific threshold, the managing physician will be notified through the electronic medical record system. Managing providers will also be sent a weekly report of weight measurements.

BEHAVIORAL

Support Partner

Participants will identify a support partner who will be contacted if the participant is non-adherent to their diuretic and/or weighing-in.

BEHAVIORAL

Engagement incentives

Participants will be entered into a daily lottery, for which their participation is contingent on adhering to their diuretic and to weighing-in on the previous day.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pennsylvania

OTHER

NCT02708654 - Automated Hovering for Congestive Heart Failure Patients | Biotech Hunter | Biotech Hunter